We are live on
!
Find out more
UOC
UBS O'Connor Portfolio holdings
AUM
$3.76B
1-Year Est. Return
62.41%
This Fund
S&P 500
This Quarter
Est. Return
+8.61%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$5.42B
AUM Growth
-$3.38B
(-38%)
Cap. Flow
-$3.75B
Cap. Flow
% of AUM
-69.25%
Top 10 Holdings %
Top 10 Hldgs %
40.63%
Holding
1,042
New
84
Increased
109
Reduced
414
Closed
284
Avg Time Held Equity + Options
3.7
quarters
Top 10 Avg Time Held Equity + Options
0.5
quarters
Top 20 Avg Time Held Equity + Options
0.8
quarters
Avg Time Held Equity only
3.7
quarters
Top 10 Avg Time Held Equity only
0.5
quarters
Top 20 Avg Time Held Equity only
0.8
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$184M |
| 2 |
STOR
STORE Capital Corporation
STOR
|
+$172M |
| 3 |
First Horizon
FHN
|
+$107M |
| 4 |
COUP
Coupa Software Incorporated
COUP
|
+$96.9M |
| 5 |
AAWW
Atlas Air Worldwide Holdings, Inc.
AAWW
|
+$64.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$572M |
| 2 |
ZEN
ZENDESK INC
ZEN
|
+$456M |
| 3 |
AVLR
Avalara, Inc.
AVLR
|
+$373M |
| 4 |
SWCH
Switch, Inc. Class A Common Stock
SWCH
|
+$271M |
| 5 |
Rogers Corp
ROG
|
+$219M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 25.7% |
| 2 | Technology | 18.31% |
| 3 | Healthcare | 15.11% |
| 4 | Miscellaneous | 11.75% |
| 5 | Real Estate | 10.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
301
Blaize Holdings
BZAI
$40.4M
| $2.83M | 0.05% |
278,023
-2,721
| -1% | -$27.5K |
2022 Q1
3 quarters
|
|
302
BioCryst Pharmaceuticals
BCRX
$2.12B
| $2.81M | 0.05% |
245,013
+28,686
| +13% | +$358K |
2022 Q1
3 quarters
|
|
|
TGR
303
DELISTED
Kimbell Tiger Acquisition Corporation
TGR
| $2.81M | 0.05% |
273,069
-2,672
| -1% | -$27.2K |
2022 Q2
2 quarters
|
|
304
Stardust Power Inc
SDST
$715K
| $2.77M | 0.05% |
27,368
| – | – |
2021 Q1
7 quarters
|
|
305
AbbVie
ABBV
$494B
| $2.76M | 0.05% |
17,102
+6,700
| +64% | +$1.03M |
2022 Q3
1 quarter
|
|
306
DELISTED
Slam Corp. Class A Ordinary Share
SLAM
| $2.74M | 0.05% |
270,951
-2,657
| -1% | -$26.6K |
2021 Q2
6 quarters
|
|
307
Aecom
ACM
$7.65B
| $2.73M | 0.05% |
32,188
-72,347
| -69% | -$5.69M |
2022 Q2
2 quarters
|
|
|
SCOB
308
DELISTED
ScION Tech Growth II Class A Ordinary Shares
SCOB
| $2.73M | 0.05% |
269,440
-2,646
| -1% | -$26.5K |
2021 Q2
6 quarters
|
|
309
DELISTED
Pyrophyte Acquisition Corp.
PHYT
| $2.71M | 0.05% |
262,511
| – | – |
2022 Q1
3 quarters
|
|
310
CME Group
CME
$100B
| $2.69M | 0.05% |
16,000
| – | – |
2022 Q2
2 quarters
|
|
311
DELISTED
Vision Sensing Acquisition Corp. Class A Common Stock
VSAC
| $2.69M | 0.05% |
259,942
-2,544
| -1% | -$25.8K |
2022 Q1
3 quarters
|
|
312
Baxter International
BAX
$12.7B
| $2.69M | 0.05% |
52,730
-50,108
| -49% | -$2.69M |
2022 Q1
3 quarters
|
|
|
SGII
313
DELISTED
Seaport Global Acquisition II Corp. Class A Common Stock
SGII
| $2.65M | 0.05% |
259,942
-2,544
| -1% | -$25.7K |
2021 Q4
4 quarters
|
|
314
Quanta Services
PWR
$106B
| $2.65M | 0.05% |
18,574
-114,904
| -86% | -$16.3M |
2022 Q2
2 quarters
|
|
|
DNZ
315
DELISTED
D and Z Media Acquisition Corp.
DNZ
| $2.61M | 0.05% |
260,886
| – | – |
2021 Q2
6 quarters
|
|
316
LSB Industries
LXU
$705M
| $2.6M | 0.05% |
+195,669
| New | +$2.92M |
2022 Q4
0 quarters
|
|
317
DELISTED
FTAC Parnassus Acquisition Corp. Class A Common Stock
FTPA
| $2.59M | 0.05% |
258,287
-2,528
| -1% | -$25.1K |
2021 Q2
6 quarters
|
|
318
Boston Scientific
BSX
$62.7B
| $2.58M | 0.05% |
55,817
-14,188
| -20% | -$614K |
2022 Q1
3 quarters
|
|
319
Xenon Pharmaceuticals
XENE
$3.5B
| $2.54M | 0.05% |
64,372
+10,164
| +19% | +$370K |
2022 Q1
3 quarters
|
|
|
AVHI
320
DELISTED
Achari Ventures Holdings Corp I
AVHI
| $2.51M | 0.05% |
236,311
-2,312
| -1% | -$23.4K |
2022 Q2
2 quarters
|
|
321
Shell
SHEL
$290B
| $2.5M | 0.05% |
43,831
-1,472
| -3% | -$81.1K |
2022 Q1
3 quarters
|
|
|
DTRT
322
DELISTED
DTRT Health Acquisition Corp. Class A Common Stock
DTRT
| $2.49M | 0.05% |
240,341
-2,952
| -1% | -$30.2K |
2021 Q4
4 quarters
|
|
323
Brandywine Realty Trust
BDN
$453M
| $2.49M | 0.05% |
404,171
-314,989
| -44% | -$2.03M |
2021 Q4
4 quarters
|
|
|
GOGN
324
DELISTED
GoGreen Investments Corporation
GOGN
| $2.48M | 0.05% |
238,623
| – | – |
2021 Q4
4 quarters
|
|
|
KNSW
325
DELISTED
KnightSwan Acquisition Corporation
KNSW
| $2.48M | 0.05% |
231,686
-2,267
| -1% | -$22.9K |
2022 Q1
3 quarters
|
|
Similar funds
FNBT
ACI
RC
A
CGL
CB
JCM
MPM
UBS O'Connor's Q4 2022 Portfolio in Review
As of Q4 2022, UBS O'Connor held 1,042 positions worth $5.42B, down 38% from $8.8B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
UBS O'Connor withdrew a net $3.75B in Q4 2022, closing 284 positions and reducing 414 holdings. Its most notable exit was Biohaven Pharmaceutical Holding Company Ltd., an estimated $572M position sold in full.
By sector, the portfolio is most concentrated in Financials at 26% of assets, up from 20% a quarter earlier, followed by Technology and Healthcare.
Against the trend, UBS O'Connor opened a new position in Coupa Software Incorporated worth $128M.
- UBS O'Connor's largest Q4 2022 buy was Coupa Software Incorporated: 1,619,333 shares worth $128M.
- UBS O'Connor added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2022, an estimated $184M increase.
- UBS O'Connor's biggest Q4 2022 reduction was Rogers Corp, cutting an estimated $219M.
- UBS O'Connor fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $572M.
- UBS O'Connor's ten largest holdings make up 41% of its $5.42B portfolio in Q4 2022.
- UBS O'Connor opened 84 new positions and closed 284 in Q4 2022.
- UBS O'Connor's portfolio value fell 38% quarter-over-quarter to $5.42B.
Based on UBS O'Connor's 13F filing for Q4 2022, filed 14 Feb 2023.